FLSM

Frazier Life Sciences Management Portfolio holdings

AUM $2.5B
This Quarter Return
-4.79%
1 Year Return
+52.94%
3 Year Return
+530.54%
5 Year Return
10 Year Return
AUM
$1.06B
AUM Growth
+$1.06B
Cap. Flow
-$30.5M
Cap. Flow %
-2.88%
Top 10 Hldgs %
68.2%
Holding
44
New
2
Increased
8
Reduced
8
Closed
3
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
AUTL
26
Autolus Therapeutics
AUTL
$383M
$10.6M 1%
3,746,857
NTLA icon
27
Intellia Therapeutics
NTLA
$1.26B
$10.5M 1%
203,684
SLN
28
Silence Therapeutics
SLN
$237M
$10.4M 0.99%
881,173
TYRA icon
29
Tyra Biosciences
TYRA
$657M
$9.83M 0.93%
1,375,065
+47,400
+4% +$339K
STRO icon
30
Sutro Biopharma
STRO
$85.6M
$9.26M 0.87%
1,776,479
ACRS icon
31
Aclaris Therapeutics
ACRS
$223M
$5.7M 0.54%
408,329
CERE
32
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$5.35M 0.5%
202,260
+146,425
+262% +$3.87M
TRVI icon
33
Trevi Therapeutics
TRVI
$871M
$3.29M 0.31%
+1,171,627
New +$3.29M
PRDS
34
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$2.6M 0.25%
845,636
-1,235,371
-59% -$3.79M
IMVT icon
35
Immunovant
IMVT
$2.91B
$2.28M 0.22%
585,759
EPIX icon
36
ESSA Pharma
EPIX
$11.2M
$2.18M 0.21%
692,910
ISEE
37
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$1.64M 0.15%
170,000
-2,251,563
-93% -$21.7M
MTEM
38
DELISTED
Molecular Templates, Inc.
MTEM
$1.25M 0.12%
1,374,047
EPZM
39
DELISTED
Epizyme, Inc
EPZM
$1.09M 0.1%
739,369
APTX
40
DELISTED
Aptinyx Inc. Common Stock
APTX
$1.05M 0.1%
1,883,244
NBRV
41
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$77K 0.01%
425,650
SRRK icon
42
Scholar Rock
SRRK
$3.3B
-156,000
Closed -$2.01M
BCYC
43
Bicycle Therapeutics
BCYC
$492M
-603,521
Closed -$26.5M
AVDL
44
Avadel Pharmaceuticals
AVDL
$1.42B
-951,814
Closed -$6.5M